

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lymph vessel development (GO:0001945) | 9.55394491 |
| 2 | vascular endothelial growth factor signaling pathway (GO:0038084) | 8.32367609 |
| 3 | endothelium development (GO:0003158) | 7.75087180 |
| 4 | lymphangiogenesis (GO:0001946) | 7.10732991 |
| 5 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 6.54038088 |
| 6 | wound healing, spreading of epidermal cells (GO:0035313) | 6.00977169 |
| 7 | positive regulation of vasculogenesis (GO:2001214) | 5.83882784 |
| 8 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 5.45522244 |
| 9 | blood vessel maturation (GO:0001955) | 5.10877510 |
| 10 | ovulation from ovarian follicle (GO:0001542) | 5.04908076 |
| 11 | surfactant homeostasis (GO:0043129) | 5.04396698 |
| 12 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 5.01808649 |
| 13 | sprouting angiogenesis (GO:0002040) | 4.98182799 |
| 14 | endothelial tube morphogenesis (GO:0061154) | 4.91391416 |
| 15 | morphogenesis of an endothelium (GO:0003159) | 4.91391416 |
| 16 | endothelial cell differentiation (GO:0045446) | 4.89690488 |
| 17 | transcytosis (GO:0045056) | 4.86845243 |
| 18 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.84317471 |
| 19 | regulation of vasculogenesis (GO:2001212) | 4.80342293 |
| 20 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 4.63881243 |
| 21 | regulation of endothelial cell differentiation (GO:0045601) | 4.60525315 |
| 22 | heart trabecula formation (GO:0060347) | 4.57017355 |
| 23 | patterning of blood vessels (GO:0001569) | 4.42760565 |
| 24 | blood vessel endothelial cell migration (GO:0043534) | 4.32629805 |
| 25 | artery development (GO:0060840) | 4.17452526 |
| 26 | basement membrane organization (GO:0071711) | 4.14241399 |
| 27 | positive regulation of urine volume (GO:0035810) | 4.07322050 |
| 28 | wound healing, spreading of cells (GO:0044319) | 4.05158904 |
| 29 | cell migration involved in sprouting angiogenesis (GO:0002042) | 4.04569221 |
| 30 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.98464451 |
| 31 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.93934004 |
| 32 | glomerular filtration (GO:0003094) | 3.93063123 |
| 33 | positive regulation of receptor recycling (GO:0001921) | 3.89354487 |
| 34 | chemical homeostasis within a tissue (GO:0048875) | 3.84936188 |
| 35 | endothelial cell morphogenesis (GO:0001886) | 3.80446488 |
| 36 | vasculogenesis (GO:0001570) | 3.78867504 |
| 37 | positive regulation of odontogenesis (GO:0042482) | 3.76050557 |
| 38 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.75836245 |
| 39 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 3.73236316 |
| 40 | negative regulation of adherens junction organization (GO:1903392) | 3.66875256 |
| 41 | negative regulation of focal adhesion assembly (GO:0051895) | 3.66875256 |
| 42 | negative regulation of cell junction assembly (GO:1901889) | 3.66875256 |
| 43 | venous blood vessel morphogenesis (GO:0048845) | 3.64195183 |
| 44 | renal filtration (GO:0097205) | 3.61737566 |
| 45 | regulation of glomerular filtration (GO:0003093) | 3.61035297 |
| 46 | negative regulation of endothelial cell migration (GO:0010596) | 3.60854408 |
| 47 | cell migration involved in heart development (GO:0060973) | 3.52677129 |
| 48 | regulation of cellular extravasation (GO:0002691) | 3.51920858 |
| 49 | embryonic heart tube development (GO:0035050) | 3.50783997 |
| 50 | establishment of endothelial barrier (GO:0061028) | 3.46823066 |
| 51 | definitive hemopoiesis (GO:0060216) | 3.40724090 |
| 52 | cell adhesion mediated by integrin (GO:0033627) | 3.38115384 |
| 53 | positive regulation of glomerulus development (GO:0090193) | 3.37300665 |
| 54 | nephron epithelium development (GO:0072009) | 3.35477914 |
| 55 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.33985937 |
| 56 | negative regulation of vascular permeability (GO:0043116) | 3.31946756 |
| 57 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.31485363 |
| 58 | regulation of sequestering of triglyceride (GO:0010889) | 3.27931078 |
| 59 | regulation of endothelial cell apoptotic process (GO:2000351) | 3.27794780 |
| 60 | positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862) | 3.23357830 |
| 61 | hyaluronan catabolic process (GO:0030214) | 3.20406417 |
| 62 | neuron remodeling (GO:0016322) | 3.19690161 |
| 63 | negative regulation of platelet activation (GO:0010544) | 3.17861931 |
| 64 | semaphorin-plexin signaling pathway (GO:0071526) | 3.17259568 |
| 65 | substrate-dependent cell migration (GO:0006929) | 3.11873994 |
| 66 | positive regulation of cell junction assembly (GO:1901890) | 3.11603077 |
| 67 | positive regulation of focal adhesion assembly (GO:0051894) | 3.11603077 |
| 68 | endothelial cell migration (GO:0043542) | 3.11536501 |
| 69 | fatty acid transmembrane transport (GO:1902001) | 3.10810345 |
| 70 | regulation of endothelial cell migration (GO:0010594) | 3.10456597 |
| 71 | regulation of urine volume (GO:0035809) | 3.08934991 |
| 72 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.07636725 |
| 73 | arginine catabolic process (GO:0006527) | 3.04057229 |
| 74 | positive regulation of endothelial cell proliferation (GO:0001938) | 3.03767247 |
| 75 | positive regulation of endothelial cell migration (GO:0010595) | 3.02619967 |
| 76 | regulation of vascular permeability (GO:0043114) | 2.99413926 |
| 77 | plasma membrane repair (GO:0001778) | 2.95905045 |
| 78 | positive regulation of epithelial cell migration (GO:0010634) | 2.93005189 |
| 79 | angiogenesis involved in wound healing (GO:0060055) | 2.92231810 |
| 80 | negative regulation of epithelial cell migration (GO:0010633) | 2.91548788 |
| 81 | anatomical structure maturation (GO:0071695) | 2.90164554 |
| 82 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.88589448 |
| 83 | extracellular fibril organization (GO:0043206) | 2.87097111 |
| 84 | sarcomere organization (GO:0045214) | 2.86807037 |
| 85 | positive regulation of adherens junction organization (GO:1903393) | 2.86227545 |
| 86 | negative regulation of protein autophosphorylation (GO:0031953) | 2.86152829 |
| 87 | trabecula morphogenesis (GO:0061383) | 2.84419478 |
| 88 | low-density lipoprotein particle clearance (GO:0034383) | 2.84371753 |
| 89 | negative regulation of anoikis (GO:2000811) | 2.83646605 |
| 90 | endothelial cell chemotaxis (GO:0035767) | 2.83502941 |
| 91 | regulation of endothelial cell proliferation (GO:0001936) | 2.82979589 |
| 92 | trabecula formation (GO:0060343) | 2.82750358 |
| 93 | negative regulation of angiogenesis (GO:0016525) | 2.82611549 |
| 94 | cardiac myofibril assembly (GO:0055003) | 2.81319238 |
| 95 | regulation of blood vessel endothelial cell migration (GO:0043535) | 2.81115025 |
| 96 | endothelial cell proliferation (GO:0001935) | 2.80081705 |
| 97 | negative regulation of blood vessel morphogenesis (GO:2000181) | 2.80052247 |
| 98 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.78472291 |
| 99 | positive regulation of protein kinase C signaling (GO:0090037) | 2.77783989 |
| 100 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.76497315 |
| 101 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.75555039 |
| 102 | detection of bacterium (GO:0016045) | 2.75152552 |
| 103 | ovulation (GO:0030728) | 2.74836850 |
| 104 | regulation of epithelial cell migration (GO:0010632) | 2.74043467 |
| 105 | coronary vasculature morphogenesis (GO:0060977) | 2.73264660 |
| 106 | negative regulation of cartilage development (GO:0061037) | 2.72931648 |
| 107 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.72244902 |
| 108 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.71014566 |
| 109 | protein kinase C signaling (GO:0070528) | 2.70918365 |
| 110 | endochondral ossification (GO:0001958) | 2.70911561 |
| 111 | replacement ossification (GO:0036075) | 2.70911561 |
| 112 | positive regulation of cartilage development (GO:0061036) | 2.70162030 |
| 113 | blood vessel remodeling (GO:0001974) | 2.69512578 |
| 114 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.68798294 |
| 115 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.68725176 |
| 116 | endocrine process (GO:0050886) | 2.68725176 |
| 117 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.68725176 |
| 118 | mRNA transcription (GO:0009299) | 2.68321271 |
| 119 | negative regulation of vasculature development (GO:1901343) | 2.67079291 |
| 120 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.66448501 |
| 121 | positive regulation of chondrocyte differentiation (GO:0032332) | 2.66040073 |
| 122 | carnitine shuttle (GO:0006853) | 2.65216210 |
| 123 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.64778323 |
| 124 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.64272510 |
| 125 | cell volume homeostasis (GO:0006884) | 2.64130467 |
| 126 | adhesion of symbiont to host (GO:0044406) | 2.62573081 |
| 127 | * angiogenesis (GO:0001525) | 2.61492228 |
| 128 | SMAD protein complex assembly (GO:0007183) | 2.60529659 |
| 129 | phagocytosis, recognition (GO:0006910) | 2.60412698 |
| 130 | cell proliferation involved in metanephros development (GO:0072203) | 2.59919732 |
| 131 | atrioventricular valve morphogenesis (GO:0003181) | 2.58177030 |
| 132 | cell-substrate junction assembly (GO:0007044) | 2.58108698 |
| 133 | endodermal cell differentiation (GO:0035987) | 2.56961751 |
| 134 | cAMP biosynthetic process (GO:0006171) | 2.55849707 |
| 135 | exocrine pancreas development (GO:0031017) | 2.53633583 |
| 136 | axon extension involved in axon guidance (GO:0048846) | 2.52821550 |
| 137 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.52821550 |
| 138 | response to mercury ion (GO:0046689) | 2.52529511 |
| 139 | cGMP-mediated signaling (GO:0019934) | 2.51366010 |
| 140 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.51201066 |
| 141 | heart trabecula morphogenesis (GO:0061384) | 2.50108032 |
| 142 | sodium-independent organic anion transport (GO:0043252) | 2.50066452 |
| 143 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.49388504 |
| 144 | regulation of cholesterol storage (GO:0010885) | 2.49213300 |
| 145 | blood vessel morphogenesis (GO:0048514) | 2.48842695 |
| 146 | detection of other organism (GO:0098543) | 2.48834317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.64402127 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.25401616 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.20106381 |
| 4 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 4.00003451 |
| 5 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.80610043 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.49808680 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.90666029 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.88270028 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.87684752 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.66813741 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.48716023 |
| 12 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.43319198 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.40534097 |
| 14 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.39294617 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.38324978 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.35169445 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.32428335 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.10532254 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.02433339 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.01441411 |
| 21 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.99770482 |
| 22 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.99770482 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.85397285 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80707888 |
| 25 | GATA1_19941826_ChIP-Seq_K562_Human | 1.80097690 |
| 26 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.74319604 |
| 27 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.73640416 |
| 28 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.72686037 |
| 29 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.72213451 |
| 30 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.70692707 |
| 31 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.70587034 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.70255793 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70206176 |
| 34 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.68806445 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.67849072 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65134563 |
| 37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.64617042 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.63724585 |
| 39 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.63039106 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62303327 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.49880992 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49548780 |
| 43 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.47993545 |
| 44 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.47993545 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.43891883 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42716893 |
| 47 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.42195409 |
| 48 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.42195409 |
| 49 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.42195409 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36270049 |
| 51 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.33150876 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28955874 |
| 53 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.26015974 |
| 54 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.21130705 |
| 55 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21015485 |
| 56 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.20631467 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20173199 |
| 58 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.16412432 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16303176 |
| 60 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15878814 |
| 61 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.15183663 |
| 62 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.14954123 |
| 63 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13443412 |
| 64 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.13401468 |
| 65 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.13167750 |
| 66 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.12616794 |
| 67 | CJUN_26792858_Chip-Seq_BT549_Human | 1.11554353 |
| 68 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.11548815 |
| 69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11181200 |
| 70 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.10847449 |
| 71 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09794397 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09746839 |
| 73 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.09606085 |
| 74 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08102635 |
| 75 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07709901 |
| 76 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.07462032 |
| 77 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.04352647 |
| 78 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03076153 |
| 79 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.02997716 |
| 80 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02984497 |
| 81 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.02706645 |
| 82 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02442110 |
| 83 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.02149742 |
| 84 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01219861 |
| 85 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00668238 |
| 86 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00668238 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00204019 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99786917 |
| 89 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98590348 |
| 90 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.98016194 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97522225 |
| 92 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96828003 |
| 93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95505908 |
| 94 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.94834500 |
| 95 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.94672951 |
| 96 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.94512508 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94055737 |
| 98 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92797645 |
| 99 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.92646900 |
| 100 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92541929 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92257226 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92202244 |
| 103 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91385696 |
| 104 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.90873774 |
| 105 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90791359 |
| 106 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.90176406 |
| 107 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.90129060 |
| 108 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89835600 |
| 109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89637690 |
| 110 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.88109422 |
| 111 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.87300963 |
| 112 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.86835073 |
| 113 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86625464 |
| 114 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.86116276 |
| 115 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.85165087 |
| 116 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.84261641 |
| 117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84210604 |
| 118 | SPI1_23127762_ChIP-Seq_K562_Human | 0.83755397 |
| 119 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83393972 |
| 120 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82497222 |
| 121 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82460743 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81642619 |
| 123 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.81412243 |
| 124 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81208712 |
| 125 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.80114476 |
| 126 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.79815130 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79094146 |
| 128 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.79067420 |
| 129 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.78375666 |
| 130 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.78163704 |
| 131 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.77081042 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75598150 |
| 133 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.75284011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 7.61016498 |
| 2 | MP0001879_abnormal_lymphatic_vessel | 5.92387674 |
| 3 | MP0005167_abnormal_blood-brain_barrier | 4.33078143 |
| 4 | MP0004272_abnormal_basement_membrane | 3.92967144 |
| 5 | MP0003724_increased_susceptibility_to | 3.50766531 |
| 6 | MP0003828_pulmonary_edema | 3.10374802 |
| 7 | MP0004147_increased_porphyrin_level | 3.08373392 |
| 8 | MP0004084_abnormal_cardiac_muscle | 3.08223519 |
| 9 | MP0006054_spinal_hemorrhage | 3.01200139 |
| 10 | MP0009278_abnormal_bone_marrow | 2.72298439 |
| 11 | MP0004215_abnormal_myocardial_fiber | 2.54816436 |
| 12 | MP0005670_abnormal_white_adipose | 2.22836889 |
| 13 | MP0000013_abnormal_adipose_tissue | 2.22109773 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.20832532 |
| 15 | MP0010030_abnormal_orbit_morphology | 2.13661178 |
| 16 | MP0006138_congestive_heart_failure | 2.10937133 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.09744433 |
| 18 | MP0004036_abnormal_muscle_relaxation | 1.91564934 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 1.86423651 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 1.79786575 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.79305733 |
| 22 | MP0004145_abnormal_muscle_electrophysio | 1.77041069 |
| 23 | MP0000751_myopathy | 1.76631605 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.73400063 |
| 25 | MP0005330_cardiomyopathy | 1.69821111 |
| 26 | MP0000767_abnormal_smooth_muscle | 1.65311588 |
| 27 | MP0002933_joint_inflammation | 1.63257297 |
| 28 | MP0003279_aneurysm | 1.62053688 |
| 29 | MP0005360_urolithiasis | 1.58702798 |
| 30 | MP0001544_abnormal_cardiovascular_syste | 1.57363703 |
| 31 | MP0005385_cardiovascular_system_phenoty | 1.57363703 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.56966162 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.56966162 |
| 34 | MP0004130_abnormal_muscle_cell | 1.54639914 |
| 35 | MP0003950_abnormal_plasma_membrane | 1.54004235 |
| 36 | MP0008775_abnormal_heart_ventricle | 1.51593696 |
| 37 | MP0010630_abnormal_cardiac_muscle | 1.49344252 |
| 38 | MP0004484_altered_response_of | 1.43711430 |
| 39 | MP0002127_abnormal_cardiovascular_syste | 1.43085558 |
| 40 | MP0002128_abnormal_blood_circulation | 1.41950633 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.41533688 |
| 42 | MP0005165_increased_susceptibility_to | 1.41391683 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.37858249 |
| 44 | MP0002972_abnormal_cardiac_muscle | 1.36578999 |
| 45 | MP0005409_darkened_coat_color | 1.36162124 |
| 46 | MP0004233_abnormal_muscle_weight | 1.34852042 |
| 47 | MP0005365_abnormal_bile_salt | 1.31120658 |
| 48 | * MP0000249_abnormal_blood_vessel | 1.27795397 |
| 49 | MP0005595_abnormal_vascular_smooth | 1.26486294 |
| 50 | MP0008004_abnormal_stomach_pH | 1.22760954 |
| 51 | MP0004085_abnormal_heartbeat | 1.20989131 |
| 52 | MP0004510_myositis | 1.19736182 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.18653928 |
| 54 | * MP0003091_abnormal_cell_migration | 1.18227974 |
| 55 | MP0005620_abnormal_muscle_contractility | 1.17987121 |
| 56 | MP0010329_abnormal_lipoprotein_level | 1.17163493 |
| 57 | MP0000343_altered_response_to | 1.16629455 |
| 58 | * MP0002925_abnormal_cardiovascular_devel | 1.14133646 |
| 59 | MP0003868_abnormal_feces_composition | 1.13837097 |
| 60 | MP0003943_abnormal_hepatobiliary_system | 1.13049210 |
| 61 | MP0005084_abnormal_gallbladder_morpholo | 1.12771626 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 1.12418595 |
| 63 | MP0004087_abnormal_muscle_fiber | 1.10665233 |
| 64 | MP0001873_stomach_inflammation | 1.10571116 |
| 65 | MP0005275_abnormal_skin_tensile | 1.08749471 |
| 66 | * MP0001614_abnormal_blood_vessel | 1.08168012 |
| 67 | MP0000749_muscle_degeneration | 1.08046674 |
| 68 | MP0008875_abnormal_xenobiotic_pharmacok | 1.03963642 |
| 69 | MP0003566_abnormal_cell_adhesion | 1.03219727 |
| 70 | MP0001851_eye_inflammation | 1.02652104 |
| 71 | MP0000266_abnormal_heart_morphology | 1.02404639 |
| 72 | MP0000003_abnormal_adipose_tissue | 1.01666873 |
| 73 | MP0000759_abnormal_skeletal_muscle | 0.98217133 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 0.95153606 |
| 75 | MP0002295_abnormal_pulmonary_circulatio | 0.94585465 |
| 76 | MP0003075_altered_response_to | 0.91637407 |
| 77 | MP0005666_abnormal_adipose_tissue | 0.87275045 |
| 78 | MP0000750_abnormal_muscle_regeneration | 0.87230856 |
| 79 | MP0005023_abnormal_wound_healing | 0.86673799 |
| 80 | MP0000230_abnormal_systemic_arterial | 0.85499297 |
| 81 | MP0005375_adipose_tissue_phenotype | 0.85162725 |
| 82 | MP0002971_abnormal_brown_adipose | 0.82693838 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 0.82612613 |
| 84 | MP0003646_muscle_fatigue | 0.82318628 |
| 85 | MP0009697_abnormal_copulation | 0.81847194 |
| 86 | MP0000733_abnormal_muscle_development | 0.80512009 |
| 87 | MP0009840_abnormal_foam_cell | 0.80024155 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 0.79399444 |
| 89 | MP0005623_abnormal_meninges_morphology | 0.78652233 |
| 90 | MP0001915_intracranial_hemorrhage | 0.78032409 |
| 91 | MP0002932_abnormal_joint_morphology | 0.77363853 |
| 92 | MP0004883_abnormal_blood_vessel | 0.76999823 |
| 93 | MP0000678_abnormal_parathyroid_gland | 0.76485226 |
| 94 | MP0005164_abnormal_response_to | 0.76321410 |
| 95 | MP0003567_abnormal_fetal_cardiomyocyte | 0.76040637 |
| 96 | MP0005319_abnormal_enzyme/_coenzyme | 0.73576502 |
| 97 | MP0003303_peritoneal_inflammation | 0.73279176 |
| 98 | MP0005388_respiratory_system_phenotype | 0.71247300 |
| 99 | MP0002133_abnormal_respiratory_system | 0.71247300 |
| 100 | MP0003948_abnormal_gas_homeostasis | 0.71126836 |
| 101 | * MP0001784_abnormal_fluid_regulation | 0.71030149 |
| 102 | MP0005166_decreased_susceptibility_to | 0.68935249 |
| 103 | MP0009115_abnormal_fat_cell | 0.68852759 |
| 104 | MP0003045_fibrosis | 0.68727496 |
| 105 | MP0008438_abnormal_cutaneous_collagen | 0.67967707 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.67458515 |
| 107 | MP0008961_abnormal_basal_metabolism | 0.66891295 |
| 108 | MP0001849_ear_inflammation | 0.65963569 |
| 109 | MP0000609_abnormal_liver_physiology | 0.65521118 |
| 110 | MP0002396_abnormal_hematopoietic_system | 0.65098476 |
| 111 | MP0002166_altered_tumor_susceptibility | 0.64834932 |
| 112 | MP0005503_abnormal_tendon_morphology | 0.64746457 |
| 113 | MP0000598_abnormal_liver_morphology | 0.64744556 |
| 114 | MP0002106_abnormal_muscle_physiology | 0.64156677 |
| 115 | MP0005257_abnormal_intraocular_pressure | 0.64110465 |
| 116 | MP0003252_abnormal_bile_duct | 0.63832961 |
| 117 | MP0000747_muscle_weakness | 0.63402848 |
| 118 | MP0009764_decreased_sensitivity_to | 0.62488881 |
| 119 | MP0002086_abnormal_extraembryonic_tissu | 0.61958564 |
| 120 | MP0001756_abnormal_urination | 0.60940883 |
| 121 | MP0005508_abnormal_skeleton_morphology | 0.60359226 |
| 122 | MP0003385_abnormal_body_wall | 0.59665722 |
| 123 | MP0002168_other_aberrant_phenotype | 0.59336975 |
| 124 | MP0002118_abnormal_lipid_homeostasis | 0.58379529 |
| 125 | MP0005369_muscle_phenotype | 0.57426097 |
| 126 | MP0009643_abnormal_urine_homeostasis | 0.57351682 |
| 127 | MP0000049_abnormal_middle_ear | 0.57056181 |
| 128 | MP0002088_abnormal_embryonic_growth/wei | 0.56328464 |
| 129 | MP0009763_increased_sensitivity_to | 0.55112434 |
| 130 | MP0003984_embryonic_growth_retardation | 0.54157083 |
| 131 | MP0003959_abnormal_lean_body | 0.53924646 |
| 132 | MP0002108_abnormal_muscle_morphology | 0.53406053 |
| 133 | MP0001958_emphysema | 0.52650472 |
| 134 | MP0003935_abnormal_craniofacial_develop | 0.52573147 |
| 135 | MP0004782_abnormal_surfactant_physiolog | 0.52102748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nonimmune hydrops fetalis (HP:0001790) | 6.08367532 |
| 2 | Polycythemia (HP:0001901) | 5.38458790 |
| 3 | Spontaneous hematomas (HP:0007420) | 5.36297887 |
| 4 | Hematochezia (HP:0002573) | 4.84041489 |
| 5 | Esophageal varix (HP:0002040) | 4.77895528 |
| 6 | Wrist flexion contracture (HP:0001239) | 4.36880459 |
| 7 | Hypoglycemic coma (HP:0001325) | 4.13227132 |
| 8 | Ventricular tachycardia (HP:0004756) | 4.10987296 |
| 9 | Muscle fiber splitting (HP:0003555) | 4.06255220 |
| 10 | Lymphangioma (HP:0100764) | 3.99900565 |
| 11 | Broad metatarsal (HP:0001783) | 3.92012529 |
| 12 | Increased connective tissue (HP:0009025) | 3.77069553 |
| 13 | Asymmetry of the thorax (HP:0001555) | 3.71759429 |
| 14 | Arterial tortuosity (HP:0005116) | 3.68474222 |
| 15 | Deep venous thrombosis (HP:0002625) | 3.64704022 |
| 16 | Congenital, generalized hypertrichosis (HP:0004540) | 3.57778536 |
| 17 | Vascular tortuosity (HP:0004948) | 3.57546848 |
| 18 | Atrial fibrillation (HP:0005110) | 3.43578040 |
| 19 | Sudden death (HP:0001699) | 3.42123528 |
| 20 | Supraventricular arrhythmia (HP:0005115) | 3.29642199 |
| 21 | Conjunctival telangiectasia (HP:0000524) | 3.22067416 |
| 22 | Cerebral hemorrhage (HP:0001342) | 3.21557663 |
| 23 | Capillary hemangiomas (HP:0005306) | 3.20692282 |
| 24 | Primary atrial arrhythmia (HP:0001692) | 3.19947471 |
| 25 | Aortic aneurysm (HP:0004942) | 3.18394252 |
| 26 | Visceral angiomatosis (HP:0100761) | 3.12346085 |
| 27 | Hemangiomatosis (HP:0007461) | 3.11078175 |
| 28 | Lipoatrophy (HP:0100578) | 3.11039661 |
| 29 | Menorrhagia (HP:0000132) | 3.09849667 |
| 30 | Hyporeflexia of lower limbs (HP:0002600) | 3.06691256 |
| 31 | Supraventricular tachycardia (HP:0004755) | 3.04477278 |
| 32 | Myotonia (HP:0002486) | 3.04387792 |
| 33 | Portal hypertension (HP:0001409) | 3.03633338 |
| 34 | Adactyly (HP:0009776) | 3.02967036 |
| 35 | Premature rupture of membranes (HP:0001788) | 3.02794284 |
| 36 | Hemorrhage of the eye (HP:0011885) | 2.97556115 |
| 37 | Cerebral aneurysm (HP:0004944) | 2.96576842 |
| 38 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.93593552 |
| 39 | Hypoglycemic seizures (HP:0002173) | 2.92979882 |
| 40 | Joint hemorrhage (HP:0005261) | 2.88895061 |
| 41 | Abnormality of the nasal mucosa (HP:0000433) | 2.81444824 |
| 42 | Cervical subluxation (HP:0003308) | 2.78187466 |
| 43 | Difficulty running (HP:0009046) | 2.77342227 |
| 44 | Abnormality of the hepatic vasculature (HP:0006707) | 2.76252713 |
| 45 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.74948031 |
| 46 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.74450890 |
| 47 | Prolonged partial thromboplastin time (HP:0003645) | 2.69255540 |
| 48 | Abnormality of the intrinsic pathway (HP:0010989) | 2.67635451 |
| 49 | Facial diplegia (HP:0001349) | 2.67340083 |
| 50 | Aortic valve stenosis (HP:0001650) | 2.65252325 |
| 51 | Exercise-induced muscle cramps (HP:0003710) | 2.62654400 |
| 52 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.60893093 |
| 53 | Overgrowth (HP:0001548) | 2.60130335 |
| 54 | Short hallux (HP:0010109) | 2.57817115 |
| 55 | Hip contracture (HP:0003273) | 2.57662516 |
| 56 | Spinal rigidity (HP:0003306) | 2.57604247 |
| 57 | Muscle stiffness (HP:0003552) | 2.54518374 |
| 58 | Acanthosis nigricans (HP:0000956) | 2.52928406 |
| 59 | Pulmonary hypertension (HP:0002092) | 2.52742251 |
| 60 | Cavernous hemangioma (HP:0001048) | 2.50284320 |
| 61 | Absent hand (HP:0004050) | 2.49980996 |
| 62 | Right ventricular cardiomyopathy (HP:0011663) | 2.49331320 |
| 63 | Skull defect (HP:0001362) | 2.48911995 |
| 64 | Aortic dissection (HP:0002647) | 2.47759732 |
| 65 | Dilated cardiomyopathy (HP:0001644) | 2.46318020 |
| 66 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.45408995 |
| 67 | Distal lower limb amyotrophy (HP:0008944) | 2.45168796 |
| 68 | Ketoacidosis (HP:0001993) | 2.43705278 |
| 69 | Ketosis (HP:0001946) | 2.43616877 |
| 70 | Shallow orbits (HP:0000586) | 2.42600262 |
| 71 | Abnormal platelet function (HP:0011869) | 2.41967599 |
| 72 | Impaired platelet aggregation (HP:0003540) | 2.41967599 |
| 73 | Porencephaly (HP:0002132) | 2.38746215 |
| 74 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.38340185 |
| 75 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.37109823 |
| 76 | Increased variability in muscle fiber diameter (HP:0003557) | 2.36604343 |
| 77 | Stroke (HP:0001297) | 2.35389344 |
| 78 | Microcytic anemia (HP:0001935) | 2.32600887 |
| 79 | Prolonged QT interval (HP:0001657) | 2.32466725 |
| 80 | Ectopia lentis (HP:0001083) | 2.31761030 |
| 81 | Insulin resistance (HP:0000855) | 2.31713745 |
| 82 | Mitral valve prolapse (HP:0001634) | 2.28653257 |
| 83 | Hypoalphalipoproteinemia (HP:0003233) | 2.27850314 |
| 84 | Growth hormone excess (HP:0000845) | 2.20754705 |
| 85 | Ileus (HP:0002595) | 2.19395452 |
| 86 | EMG: myopathic abnormalities (HP:0003458) | 2.18658812 |
| 87 | Wormian bones (HP:0002645) | 2.18324256 |
| 88 | Hypoplastic ischia (HP:0003175) | 2.17829813 |
| 89 | Atrioventricular block (HP:0001678) | 2.16733943 |
| 90 | Vertebral clefting (HP:0008428) | 2.15762528 |
| 91 | Joint contractures involving the joints of the feet (HP:0100492) | 2.15509786 |
| 92 | Flexion contracture of toe (HP:0005830) | 2.15509786 |
| 93 | Large hands (HP:0001176) | 2.14963313 |
| 94 | Pigmentary retinal degeneration (HP:0001146) | 2.14774106 |
| 95 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14437046 |
| 96 | Joint stiffness (HP:0001387) | 2.13341463 |
| 97 | Exercise-induced myalgia (HP:0003738) | 2.12427803 |
| 98 | Venous insufficiency (HP:0005293) | 2.11125003 |
| 99 | Broad face (HP:0000283) | 2.10574318 |
| 100 | Hypertriglyceridemia (HP:0002155) | 2.10418184 |
| 101 | Myoglobinuria (HP:0002913) | 2.10261051 |
| 102 | High pitched voice (HP:0001620) | 2.09495392 |
| 103 | Abnormal vertebral ossification (HP:0100569) | 2.09169822 |
| 104 | Mucosal telangiectasiae (HP:0100579) | 2.07683840 |
| 105 | Subaortic stenosis (HP:0001682) | 2.07456746 |
| 106 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.07456746 |
| 107 | Dicarboxylic aciduria (HP:0003215) | 2.07067991 |
| 108 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.07067991 |
| 109 | Coxa vara (HP:0002812) | 2.06367007 |
| 110 | Pulmonary embolism (HP:0002204) | 2.05964080 |
| 111 | Neonatal death (HP:0003811) | 2.05878303 |
| 112 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.05797729 |
| 113 | Muscle fiber inclusion bodies (HP:0100299) | 2.04785332 |
| 114 | Lymphedema (HP:0001004) | 2.04592973 |
| 115 | Abnormality of the ischium (HP:0003174) | 2.04230664 |
| 116 | Limited hip movement (HP:0008800) | 2.03075685 |
| 117 | Nemaline bodies (HP:0003798) | 2.01276152 |
| 118 | Interstitial pulmonary disease (HP:0006530) | 2.00866455 |
| 119 | Hyperlipoproteinemia (HP:0010980) | 1.99786906 |
| 120 | Type 1 muscle fiber predominance (HP:0003803) | 1.99624524 |
| 121 | Pulmonary artery stenosis (HP:0004415) | 1.99132685 |
| 122 | Generalized muscle weakness (HP:0003324) | 1.98672831 |
| 123 | Hyperammonemia (HP:0001987) | 1.98629403 |
| 124 | Asymmetric septal hypertrophy (HP:0001670) | 1.98580621 |
| 125 | Venous abnormality (HP:0002624) | 1.98224449 |
| 126 | Aneurysm (HP:0002617) | 1.97354426 |
| 127 | Trismus (HP:0000211) | 1.96728535 |
| 128 | Difficulty climbing stairs (HP:0003551) | 1.96311744 |
| 129 | Polygenic inheritance (HP:0010982) | 1.95705607 |
| 130 | Malignant hyperthermia (HP:0002047) | 1.95343062 |
| 131 | Areflexia of lower limbs (HP:0002522) | 1.94405419 |
| 132 | Tetraparesis (HP:0002273) | 1.93724176 |
| 133 | Mesangial abnormality (HP:0001966) | 1.93139544 |
| 134 | Xanthomatosis (HP:0000991) | 1.92954273 |
| 135 | Round ear (HP:0100830) | 1.92565463 |
| 136 | Protrusio acetabuli (HP:0003179) | 1.92542349 |
| 137 | Absent toe (HP:0010760) | 1.92117307 |
| 138 | Large for gestational age (HP:0001520) | 1.90486635 |
| 139 | Distal lower limb muscle weakness (HP:0009053) | 1.88669164 |
| 140 | Neck muscle weakness (HP:0000467) | 1.88474747 |
| 141 | Myocardial infarction (HP:0001658) | 1.87259264 |
| 142 | Short nail (HP:0001799) | 1.87102244 |
| 143 | Epistaxis (HP:0000421) | 1.85076434 |
| 144 | Short 4th metacarpal (HP:0010044) | 1.84313886 |
| 145 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.84313886 |
| 146 | Glucose intolerance (HP:0000833) | 1.81172788 |
| 147 | Hypoplasia of the iris (HP:0007676) | 1.80274448 |
| 148 | Striae distensae (HP:0001065) | 1.78792300 |
| 149 | Distal arthrogryposis (HP:0005684) | 1.77942136 |
| 150 | Blue sclerae (HP:0000592) | 1.77471066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 8.66365339 |
| 2 | TGFBR2 | 3.41117349 |
| 3 | TGFBR1 | 2.58170911 |
| 4 | INSRR | 2.55625361 |
| 5 | GRK1 | 2.32520115 |
| 6 | TIE1 | 10.5294875 |
| 7 | PTK2B | 1.52719736 |
| 8 | RIPK1 | 1.49982573 |
| 9 | MYLK | 1.45496831 |
| 10 | ERN1 | 1.43563703 |
| 11 | MAP2K3 | 1.42332585 |
| 12 | NLK | 1.40776530 |
| 13 | TTN | 1.39851400 |
| 14 | NTRK1 | 1.33588366 |
| 15 | EPHB2 | 1.28764617 |
| 16 | BCKDK | 1.20537901 |
| 17 | PKN2 | 1.20209254 |
| 18 | CAMK1D | 1.18426609 |
| 19 | MAPK12 | 1.18028611 |
| 20 | EPHA2 | 1.16015326 |
| 21 | PRKG2 | 1.12994716 |
| 22 | TESK1 | 1.08668761 |
| 23 | TRPM7 | 1.07802093 |
| 24 | PDK2 | 1.04823468 |
| 25 | PTK6 | 1.02239173 |
| 26 | DMPK | 0.98728471 |
| 27 | MOS | 0.95744381 |
| 28 | FGFR4 | 0.94128754 |
| 29 | MAPK7 | 0.91402290 |
| 30 | PRKAA2 | 0.85263925 |
| 31 | EPHB1 | 0.84810275 |
| 32 | CAMK4 | 0.84341764 |
| 33 | MAP3K6 | 0.82410485 |
| 34 | TEC | 0.81893168 |
| 35 | TRIB3 | 0.79505408 |
| 36 | MAP3K3 | 0.78054202 |
| 37 | FLT3 | 0.78040491 |
| 38 | CAMK1G | 0.77554976 |
| 39 | FER | 0.76568493 |
| 40 | PDGFRA | 0.75743355 |
| 41 | FGFR2 | 0.73829032 |
| 42 | FRK | 0.71317353 |
| 43 | MAP2K2 | 0.69404725 |
| 44 | PAK4 | 0.67755290 |
| 45 | MAPK15 | 0.67129499 |
| 46 | PRKD1 | 0.65516632 |
| 47 | RPS6KA2 | 0.65402095 |
| 48 | EEF2K | 0.65388553 |
| 49 | LIMK1 | 0.61941003 |
| 50 | LMTK2 | 0.60547834 |
| 51 | JAK1 | 0.59455240 |
| 52 | FGFR3 | 0.59394424 |
| 53 | JAK3 | 0.59363422 |
| 54 | CSK | 0.58973761 |
| 55 | ROCK1 | 0.58783951 |
| 56 | OBSCN | 0.58781466 |
| 57 | MAP3K11 | 0.56401325 |
| 58 | LATS2 | 0.55382173 |
| 59 | PHKG1 | 0.54313938 |
| 60 | PHKG2 | 0.54313938 |
| 61 | DAPK3 | 0.53648369 |
| 62 | GRK5 | 0.53222076 |
| 63 | GSK3A | 0.52100847 |
| 64 | IGF1R | 0.51548627 |
| 65 | ROCK2 | 0.50558026 |
| 66 | SIK1 | 0.46675203 |
| 67 | TYK2 | 0.45135914 |
| 68 | STK38 | 0.45094322 |
| 69 | MAP4K1 | 0.43169064 |
| 70 | JAK2 | 0.43132532 |
| 71 | ARAF | 0.42890600 |
| 72 | PTK2 | 0.41183667 |
| 73 | LRRK2 | 0.40705300 |
| 74 | ICK | 0.40016531 |
| 75 | CDC42BPA | 0.39629559 |
| 76 | MAP3K1 | 0.38761993 |
| 77 | DDR2 | 0.38654402 |
| 78 | MAP3K7 | 0.38222224 |
| 79 | PINK1 | 0.38156449 |
| 80 | PRKCH | 0.36171405 |
| 81 | ITK | 0.34937105 |
| 82 | KIT | 0.34584419 |
| 83 | MAP3K13 | 0.32521173 |
| 84 | HCK | 0.31627201 |
| 85 | MAPKAPK5 | 0.31236225 |
| 86 | CDK9 | 0.31137449 |
| 87 | PDK4 | 0.30936085 |
| 88 | PDK3 | 0.30936085 |
| 89 | TBK1 | 0.30936035 |
| 90 | SRC | 0.30652991 |
| 91 | FES | 0.30607091 |
| 92 | NEK9 | 0.30543944 |
| 93 | MAP2K1 | 0.30527261 |
| 94 | CDK8 | 0.30126670 |
| 95 | SGK3 | 0.29052626 |
| 96 | MAPKAPK3 | 0.28511575 |
| 97 | DAPK2 | 0.27419809 |
| 98 | MATK | 0.27250506 |
| 99 | PRKAA1 | 0.26768323 |
| 100 | EGFR | 0.25778277 |
| 101 | MARK2 | 0.25238602 |
| 102 | WNK4 | 0.24871270 |
| 103 | SMG1 | 0.24374130 |
| 104 | IRAK3 | 0.24298515 |
| 105 | MAPK4 | 0.24211030 |
| 106 | PIK3CA | 0.23598656 |
| 107 | CAMK1 | 0.23571340 |
| 108 | ERBB4 | 0.23424240 |
| 109 | PRKD2 | 0.22531620 |
| 110 | RET | 0.22449689 |
| 111 | HIPK2 | 0.22322653 |
| 112 | INSR | 0.22294185 |
| 113 | PAK2 | 0.20109324 |
| 114 | SGK2 | 0.18853813 |
| 115 | CDK6 | 0.18823281 |
| 116 | DAPK1 | 0.18411595 |
| 117 | PRKCE | 0.16959528 |
| 118 | PRKD3 | 0.15491952 |
| 119 | TSSK6 | 0.15434379 |
| 120 | PDGFRB | 0.15330442 |
| 121 | MTOR | 0.15106508 |
| 122 | BTK | 0.14921129 |
| 123 | MET | 0.14547656 |
| 124 | ZAP70 | 0.14178991 |
| 125 | STK10 | 0.13269399 |
| 126 | ZAK | 0.13251321 |
| 127 | EPHA3 | 0.12572985 |
| 128 | PDPK1 | 0.12271356 |
| 129 | ILK | 0.11796434 |
| 130 | ABL2 | 0.10360863 |
| 131 | PRKACB | 0.09168450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.96674090 |
| 2 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.76474463 |
| 3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.61481563 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56571879 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.50703688 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.47932407 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.36441962 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.23852333 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.19419950 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14772832 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.12531002 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.99038165 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.94273336 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 1.90137641 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89280081 |
| 16 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.79684946 |
| 17 | Focal adhesion_Homo sapiens_hsa04510 | 1.78764348 |
| 18 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.76270344 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.75086075 |
| 20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.73816154 |
| 21 | Adherens junction_Homo sapiens_hsa04520 | 1.73244472 |
| 22 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.72237064 |
| 23 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.55368853 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.54525966 |
| 25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.52177398 |
| 26 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.49610518 |
| 27 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.46879256 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.45251205 |
| 29 | Prion diseases_Homo sapiens_hsa05020 | 1.44679367 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.41281976 |
| 31 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.25221972 |
| 32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.24834617 |
| 33 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.22546154 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 1.21761154 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18981498 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.18541612 |
| 37 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.17779248 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.14887800 |
| 39 | Bladder cancer_Homo sapiens_hsa05219 | 1.10528497 |
| 40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.10036471 |
| 41 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.08820745 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04191833 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.01476657 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.99921886 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98383835 |
| 46 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.97602367 |
| 47 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97281516 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.95016295 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94364438 |
| 50 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.92400222 |
| 51 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.92382649 |
| 52 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.91662869 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91330084 |
| 54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.88659621 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88615919 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87506582 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87221132 |
| 58 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.87128470 |
| 59 | Amoebiasis_Homo sapiens_hsa05146 | 0.87090477 |
| 60 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.86607254 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85084999 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84562806 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81371054 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80778257 |
| 65 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.80039913 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79145613 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.78812913 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.78596354 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78278535 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.77360949 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77348809 |
| 72 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75139251 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.74772755 |
| 74 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74394702 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73937615 |
| 76 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72604966 |
| 77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71936884 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 0.71907567 |
| 79 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.70642607 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.66938443 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66901933 |
| 82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66571799 |
| 83 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65989552 |
| 84 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.64664897 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64593548 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63223620 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62513977 |
| 88 | Melanogenesis_Homo sapiens_hsa04916 | 0.62446721 |
| 89 | Pathways in cancer_Homo sapiens_hsa05200 | 0.61692436 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60509673 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60446652 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58204197 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57965616 |
| 94 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57840530 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57120926 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56620620 |
| 97 | Salivary secretion_Homo sapiens_hsa04970 | 0.55540550 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.55007219 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53773301 |
| 100 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53144294 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52764907 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.52050314 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49657695 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49620986 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49381650 |
| 106 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.49356841 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48903952 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48073165 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47888769 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47636787 |
| 111 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47602448 |
| 112 | Gap junction_Homo sapiens_hsa04540 | 0.46151427 |
| 113 | Long-term depression_Homo sapiens_hsa04730 | 0.46059710 |
| 114 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45784238 |
| 115 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45726481 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45688501 |
| 117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45016913 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44371823 |
| 119 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.44270554 |
| 120 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43940367 |
| 121 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43835019 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43646446 |
| 123 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43272435 |
| 124 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42071653 |
| 125 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.41929795 |
| 126 | Lysosome_Homo sapiens_hsa04142 | 0.41718658 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41453536 |
| 128 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.40555124 |
| 129 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40226681 |
| 130 | Axon guidance_Homo sapiens_hsa04360 | 0.39820511 |
| 131 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39697439 |
| 132 | Pertussis_Homo sapiens_hsa05133 | 0.39353267 |
| 133 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39032279 |
| 134 | Hepatitis C_Homo sapiens_hsa05160 | 0.38584234 |
| 135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38567872 |
| 136 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.38212469 |
| 137 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.37700486 |
| 138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37648042 |
| 139 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36646967 |
| 140 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36597675 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36068435 |
| 142 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35975808 |
| 143 | Shigellosis_Homo sapiens_hsa05131 | 0.35103717 |

